LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 8 of total 8

Search options

  1. Article ; Online: Induction of oligodendrocyte differentiation and in vitro myelination by inhibition of rho-associated kinase.

    Pedraza, Carlos E / Taylor, Christopher / Pereira, Albertina / Seng, Michelle / Tham, Chui-Se / Izrael, Michal / Webb, Michael

    ASN neuro

    2014  Volume 6, Issue 4

    Abstract: In inflammatory demyelinating diseases such as multiple sclerosis (MS), myelin degradation results in loss of axonal function and eventual axonal degeneration. Differentiation of resident oligodendrocyte precursor cells (OPCs) leading to remyelination of ...

    Abstract In inflammatory demyelinating diseases such as multiple sclerosis (MS), myelin degradation results in loss of axonal function and eventual axonal degeneration. Differentiation of resident oligodendrocyte precursor cells (OPCs) leading to remyelination of denuded axons occurs regularly in early stages of MS but halts as the pathology transitions into progressive MS. Pharmacological potentiation of endogenous OPC maturation and remyelination is now recognized as a promising therapeutic approach for MS. In this study, we analyzed the effects of modulating the Rho-A/Rho-associated kinase (ROCK) signaling pathway, by the use of selective inhibitors of ROCK, on the transformation of OPCs into mature, myelinating oligodendrocytes. Here we demonstrate, with the use of cellular cultures from rodent and human origin, that ROCK inhibition in OPCs results in a significant generation of branches and cell processes in early differentiation stages, followed by accelerated production of myelin protein as an indication of advanced maturation. Furthermore, inhibition of ROCK enhanced myelin formation in cocultures of human OPCs and neurons and remyelination in rat cerebellar tissue explants previously demyelinated with lysolecithin. Our findings indicate that by direct inhibition of this signaling molecule, the OPC differentiation program is activated resulting in morphological and functional cell maturation, myelin formation, and regeneration. Altogether, we show evidence of modulation of the Rho-A/ROCK signaling pathway as a viable target for the induction of remyelination in demyelinating pathologies.
    MeSH term(s) Animals ; Animals, Newborn ; Brain/cytology ; Cell Differentiation/drug effects ; Cell Differentiation/physiology ; Cells, Cultured ; Coculture Techniques ; Embryo, Mammalian ; Enzyme Inhibitors/pharmacology ; Ganglia, Spinal/cytology ; Humans ; In Vitro Techniques ; Mice ; Mice, Inbred C57BL ; Myelin Proteins/metabolism ; Myelin Sheath/metabolism ; Nerve Growth Factor/pharmacology ; Nerve Tissue Proteins/genetics ; Nerve Tissue Proteins/metabolism ; Neuroglia/physiology ; Oligodendroglia ; Optic Nerve/cytology ; Rats ; Stem Cells ; Time Factors ; rho-Associated Kinases/metabolism
    Chemical Substances Enzyme Inhibitors ; Myelin Proteins ; Nerve Tissue Proteins ; Nerve Growth Factor (9061-61-4) ; rho-Associated Kinases (EC 2.7.11.1)
    Language English
    Publishing date 2014-06-25
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2485467-0
    ISSN 1759-0914 ; 1759-0914
    ISSN (online) 1759-0914
    ISSN 1759-0914
    DOI 10.1177/1759091414538134
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Genetic deletion of Fatty Acid Amide Hydrolase results in improved long-term outcome in chronic autoimmune encephalitis.

    Webb, Michael / Luo, Lin / Ma, Jing Ying / Tham, Chui-Se

    Neuroscience letters

    2008  Volume 439, Issue 1, Page(s) 106–110

    Abstract: The enzyme Fatty Acid Amide Hydrolase (FAAH) is a key regulator of the endogenous levels of a family of biologically active lipid mediators, the fatty acid amides. These include anandamide, oleoyl ethanolamide and palmitoyl ethanolamide, and their ... ...

    Abstract The enzyme Fatty Acid Amide Hydrolase (FAAH) is a key regulator of the endogenous levels of a family of biologically active lipid mediators, the fatty acid amides. These include anandamide, oleoyl ethanolamide and palmitoyl ethanolamide, and their effects are mediated by a variety of downstream targets including cannabinoid receptors and peroxisome proliferator-activated receptors (PPARs). Activation of both of these may have anti-inflammatory and neuroprotective effects. Levels of all three mediators are low in normal nervous tissue, but substantially elevated in mice lacking FAAH as a result of genetic deletion. There is a long anecdotal history of cannabis use by patients suffering from multiple sclerosis, and preclinical studies have indicated beneficial effects of cannabinoid receptor stimulation on both long-term outcome and acute muscle spasm in rodent models of multiple sclerosis (experimental autoimmune encephalitis; EAE). Thus far no report has appeared on the effect of inhibition of FAAH on the progression of EAE. Using a chronic mouse EAE model, we present data indicating that mice lacking FAAH experience an initial inflammatory phase of EAE similar in severity to wild type controls, but exhibited a more substantial clinical remission compared to wild type mice.
    MeSH term(s) Amidohydrolases/deficiency ; Animals ; CD3 Complex/metabolism ; Chronic Disease ; Demyelinating Diseases/etiology ; Disease Models, Animal ; Encephalomyelitis, Autoimmune, Experimental/chemically induced ; Encephalomyelitis, Autoimmune, Experimental/genetics ; Encephalomyelitis, Autoimmune, Experimental/pathology ; Encephalomyelitis, Autoimmune, Experimental/physiopathology ; Glycoproteins ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Myelin-Oligodendrocyte Glycoprotein ; Peptide Fragments ; Spinal Cord/pathology ; T-Lymphocytes/pathology ; T-Lymphocytes/physiology ; Time Factors
    Chemical Substances CD3 Complex ; Glycoproteins ; Myelin-Oligodendrocyte Glycoprotein ; Peptide Fragments ; myelin oligodendrocyte glycoprotein (35-55) ; Amidohydrolases (EC 3.5.-) ; fatty-acid amide hydrolase (EC 3.5.1.-)
    Language English
    Publishing date 2008-07-04
    Publishing country Ireland
    Document type Journal Article
    ZDB-ID 194929-9
    ISSN 1872-7972 ; 0304-3940
    ISSN (online) 1872-7972
    ISSN 0304-3940
    DOI 10.1016/j.neulet.2008.04.090
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Inhibition of microglial fatty acid amide hydrolase modulates LPS stimulated release of inflammatory mediators.

    Tham, Chui-Se / Whitaker, John / Luo, Lin / Webb, Michael

    FEBS letters

    2007  Volume 581, Issue 16, Page(s) 2899–2904

    Abstract: Anandamide and other fatty acid amides are metabolised by the enzyme fatty acid amide hydrolase (FAAH), which thereby regulates their endogenous levels. Here we demonstrate that cultured rat cortical microglia express FAAH at low levels. The potent FAAH ... ...

    Abstract Anandamide and other fatty acid amides are metabolised by the enzyme fatty acid amide hydrolase (FAAH), which thereby regulates their endogenous levels. Here we demonstrate that cultured rat cortical microglia express FAAH at low levels. The potent FAAH inhibitor URB597 reduced the LPS stimulated microglial expression of cyclo-oxygenase 2 and inducible nitric oxide, with concomitant attenuation of the release of PGE2 and NO. Additional of supplemental exogenous anandamide did not increase the magnitude of attenuation of mediator release. The effect of URB597 on LPS stimulated PGE2 release was not blocked by selective CB1 or CB2 receptor antagonists.
    MeSH term(s) Amidohydrolases/antagonists & inhibitors ; Amidohydrolases/physiology ; Animals ; Benzamides/pharmacology ; Carbamates/pharmacology ; Cells, Cultured ; Cyclooxygenase 2/metabolism ; Dinoprostone/secretion ; Inflammation Mediators/metabolism ; Lipopolysaccharides/pharmacology ; Microglia/drug effects ; Microglia/enzymology ; Microglia/secretion ; Nitric Oxide/secretion ; Nitric Oxide Synthase Type II/metabolism ; Rats ; Tumor Necrosis Factor-alpha/secretion
    Chemical Substances Benzamides ; Carbamates ; Inflammation Mediators ; Lipopolysaccharides ; Tumor Necrosis Factor-alpha ; cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester ; Nitric Oxide (31C4KY9ESH) ; Nitric Oxide Synthase Type II (EC 1.14.13.39) ; Nos2 protein, rat (EC 1.14.13.39) ; Cyclooxygenase 2 (EC 1.14.99.1) ; Ptgs2 protein, rat (EC 1.14.99.1) ; Amidohydrolases (EC 3.5.-) ; fatty-acid amide hydrolase (EC 3.5.1.-) ; Dinoprostone (K7Q1JQR04M)
    Language English
    Publishing date 2007-06-26
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 212746-5
    ISSN 1873-3468 ; 0014-5793
    ISSN (online) 1873-3468
    ISSN 0014-5793
    DOI 10.1016/j.febslet.2007.05.037
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Microglial activation state and lysophospholipid acid receptor expression.

    Tham, Chui-Se / Lin, Fen-Fen / Rao, Tadimeti S / Yu, Naichen / Webb, Michael

    International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience

    2003  Volume 21, Issue 8, Page(s) 431–443

    Abstract: We used a simple commercial magnetic immunobead method for the preparation of acutely isolated microglial cells from postnatal days 1-3 rat brain. With the exception of a 15 min enzyme incubation, all stages are carried out at 4 degrees C, minimizing the ...

    Abstract We used a simple commercial magnetic immunobead method for the preparation of acutely isolated microglial cells from postnatal days 1-3 rat brain. With the exception of a 15 min enzyme incubation, all stages are carried out at 4 degrees C, minimizing the opportunity for changes in gene expression during the isolation to be reflected in changes in accumulated mRNA. The composition of the isolated cells was compared with that of microglial cultures prepared by conventional tissue culture methods, and the purity of microglia was comparable between the two preparations. RT-PCR analysis of several genes related to inflammatory products indicated that the acutely prepared cells were in a less activated condition than the conventionally tissue cultured cells. We examined the pattern of expression of receptors for lysophosphatidic acid (lpa) and sphingosine-1-phosphate (S1P) using quantitative real-time PCR (TaqMan PCR) techniques. mRNA for LPA1, S1P1, S1P2, S1P3 and S1P5 was detected in these preparations, but the levels of the different receptor mRNAs varied according to the state of activation of the cells. mRNA for LPA3 was only detected significantly in cultured cell after lipopolysaccharide (LPS) stimulation, being almost absent in cultured microglia and undetectable in the acutely isolated preparations. The levels of mRNA of LPA1 and S1P receptors was reduced by overnight exposure to S1P, while the same treatment significantly up-regulated the level of LPA3 mRNA.
    MeSH term(s) Animals ; Animals, Newborn ; Astrocytes/metabolism ; Base Sequence ; Blotting, Northern ; CD11b Antigen/genetics ; CD11b Antigen/metabolism ; Carrier Proteins/genetics ; Carrier Proteins/metabolism ; Cells, Cultured ; Cyclooxygenase 2 ; Dose-Response Relationship, Drug ; Drug Interactions ; Enzyme Inhibitors/pharmacology ; Enzyme-Linked Immunosorbent Assay ; Fluorescent Antibody Technique/methods ; Gene Expression/drug effects ; Glial Fibrillary Acidic Protein/metabolism ; Imidazoles/pharmacology ; Indoles/metabolism ; Interleukin-6/genetics ; Interleukin-6/metabolism ; Isoenzymes/genetics ; Isoenzymes/metabolism ; Lectins/metabolism ; Lysophospholipids/pharmacology ; Microglia/metabolism ; Myelin Basic Protein/metabolism ; Nitric Oxide Synthase/genetics ; Nitric Oxide Synthase/metabolism ; Nitric Oxide Synthase Type II ; Oligodendroglia/metabolism ; Osteopontin ; Prostaglandin-Endoperoxide Synthases/genetics ; Prostaglandin-Endoperoxide Synthases/metabolism ; Pyridines/pharmacology ; RNA, Messenger/biosynthesis ; Rats ; Rats, Sprague-Dawley ; Receptors, G-Protein-Coupled/biosynthesis ; Receptors, G-Protein-Coupled/genetics ; Receptors, Lipoprotein/biosynthesis ; Receptors, Lipoprotein/drug effects ; Receptors, Lipoprotein/genetics ; Receptors, Lysophospholipid ; Reverse Transcriptase Polymerase Chain Reaction/methods ; Sialoglycoproteins/genetics ; Sialoglycoproteins/metabolism ; Tumor Necrosis Factor-alpha/metabolism ; p38 Mitogen-Activated Protein Kinases
    Chemical Substances CD11b Antigen ; Carrier Proteins ; Enzyme Inhibitors ; Glial Fibrillary Acidic Protein ; Imidazoles ; Indoles ; Interleukin-6 ; Isoenzymes ; Lectins ; Lysophospholipids ; Myelin Basic Protein ; Pyridines ; RNA, Messenger ; Receptors, G-Protein-Coupled ; Receptors, Lipoprotein ; Receptors, Lysophospholipid ; Sialoglycoproteins ; Spp1 protein, rat ; Tumor Necrosis Factor-alpha ; Osteopontin (106441-73-0) ; DAPI (47165-04-8) ; Nitric Oxide Synthase (EC 1.14.13.39) ; Nitric Oxide Synthase Type II (EC 1.14.13.39) ; Nos2 protein, rat (EC 1.14.13.39) ; Cyclooxygenase 2 (EC 1.14.99.1) ; Prostaglandin-Endoperoxide Synthases (EC 1.14.99.1) ; p38 Mitogen-Activated Protein Kinases (EC 2.7.11.24) ; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole (PVX798P8GI)
    Language English
    Publishing date 2003-12
    Publishing country United States
    Document type Comparative Study ; Journal Article
    ZDB-ID 605533-3
    ISSN 1873-474X ; 0736-5748
    ISSN (online) 1873-474X
    ISSN 0736-5748
    DOI 10.1016/j.ijdevneu.2003.09.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Growth factor pre-treatment differentially regulates phosphoinositide turnover downstream of lysophospholipid receptor and metabotropic glutamate receptors in cultured rat cerebrocortical astrocytes.

    Rao, Tadimeti S / Lariosa-Willingham, Karen D / Lin, Fen-Fen / Yu, Naichen / Tham, Chui-Se / Chun, Jerold / Webb, Michael

    International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience

    2004  Volume 22, Issue 3, Page(s) 131–135

    Abstract: Reactive gliosis is an aspect of neural plasticity and growth factor (GF) stimulation of astrocytes in vitro is widely regarded as a model system to study astrocyte plasticity. Astrocytes express receptors for several ligands including lysophosphatidic ... ...

    Abstract Reactive gliosis is an aspect of neural plasticity and growth factor (GF) stimulation of astrocytes in vitro is widely regarded as a model system to study astrocyte plasticity. Astrocytes express receptors for several ligands including lysophosphatidic acid (LPA) and sphingosine-1-phosphate (S1P), agonists for the G-protein-coupled lysophospholipid receptors (lpRs). Activation of lpRs by LPA or S1P leads to multiple pharmacological effects including the influx of calcium, phosphoinositide (PI) hydrolysis, phosphorylation of extracellular receptor regulated kinase (ERK), release of arachidonic acid, and induces mitogenesis. Treatment of astrocytes in vitro with a growth factor cocktail (containing epidermal growth factor [EGF], basic fibroblast growth factor [bFGF] and insulin) led to a marked attenuation of lpR-induced PI hydrolysis. In contrast, under identical conditions, GF treatment led to marked potentiation of PI hydrolysis downstream of activation of another abundantly expressed G-protein coupled receptor, mGluR5. Quantitative gene expression analysis of GF-treated or control astrocytes by TaqMan RT-PCR indicated that GF treatment did not change gene expression of lpa1 and s1p1, but increased gene expression of s1p5 which is expressed at very low levels in basal conditions. These results suggest that GF differentially affected PLC activation downstream of mGluR5 versus lpR activation and that the changes in mRNA levels of lpRs do not account for marked attenuation of agonist-induced phosphoinositide turnover.
    MeSH term(s) Animals ; Astrocytes/drug effects ; Astrocytes/metabolism ; Cells, Cultured ; Cerebral Cortex/drug effects ; Cerebral Cortex/metabolism ; Dose-Response Relationship, Drug ; Epidermal Growth Factor/pharmacology ; Fibroblast Growth Factor 2/pharmacology ; Growth Substances/pharmacology ; Homeostasis/drug effects ; Homeostasis/physiology ; Inositol Phosphates/metabolism ; Insulin/pharmacology ; Phosphatidylinositols/metabolism ; Phosphorylation ; Rats ; Rats, Sprague-Dawley ; Receptor, Metabotropic Glutamate 5 ; Receptors, G-Protein-Coupled/metabolism ; Receptors, Lysophospholipid ; Receptors, Metabotropic Glutamate/metabolism ; Signal Transduction/drug effects ; Signal Transduction/physiology
    Chemical Substances Grm5 protein, rat ; Growth Substances ; Inositol Phosphates ; Insulin ; Phosphatidylinositols ; Receptor, Metabotropic Glutamate 5 ; Receptors, G-Protein-Coupled ; Receptors, Lysophospholipid ; Receptors, Metabotropic Glutamate ; Fibroblast Growth Factor 2 (103107-01-3) ; Epidermal Growth Factor (62229-50-9)
    Language English
    Publishing date 2004-01-19
    Publishing country United States
    Document type Journal Article
    ZDB-ID 605533-3
    ISSN 1873-474X ; 0736-5748
    ISSN (online) 1873-474X
    ISSN 0736-5748
    DOI 10.1016/j.ijdevneu.2004.03.005
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Thiadiazolopiperazinyl ureas as inhibitors of fatty acid amide hydrolase.

    Keith, John M / Apodaca, Richard / Xiao, Wei / Seierstad, Mark / Pattabiraman, Kanaka / Wu, Jiejun / Webb, Michael / Karbarz, Mark J / Brown, Sean / Wilson, Sandy / Scott, Brian / Tham, Chui-Se / Luo, Lin / Palmer, James / Wennerholm, Michelle / Chaplan, Sandra / Breitenbucher, J Guy

    Bioorganic & medicinal chemistry letters

    2008  Volume 18, Issue 17, Page(s) 4838–4843

    Abstract: A series of thiadiazolopiperazinyl aryl urea fatty acid amide hydrolase (FAAH) inhibitors is described. The molecules were found to inhibit the enzyme by acting as mechanism-based substrates, forming a covalent bond with Ser241. SAR and PK properties are ...

    Abstract A series of thiadiazolopiperazinyl aryl urea fatty acid amide hydrolase (FAAH) inhibitors is described. The molecules were found to inhibit the enzyme by acting as mechanism-based substrates, forming a covalent bond with Ser241. SAR and PK properties are presented.
    MeSH term(s) Amidohydrolases/antagonists & inhibitors ; Amidohydrolases/deficiency ; Amidohydrolases/genetics ; Animals ; Mice ; Mice, Knockout ; Piperazines/chemistry ; Piperazines/pharmacokinetics ; Piperazines/pharmacology ; Thiadiazoles/chemistry ; Thiadiazoles/pharmacokinetics ; Thiadiazoles/pharmacology ; Urea/analogs & derivatives ; Urea/chemistry ; Urea/pharmacokinetics ; Urea/pharmacology
    Chemical Substances Piperazines ; Thiadiazoles ; Urea (8W8T17847W) ; Amidohydrolases (EC 3.5.-) ; fatty-acid amide hydrolase (EC 3.5.1.-)
    Language English
    Publishing date 2008-09-01
    Publishing country England
    Document type Comparative Study ; Journal Article
    ZDB-ID 1063195-1
    ISSN 1464-3405 ; 0960-894X
    ISSN (online) 1464-3405
    ISSN 0960-894X
    DOI 10.1016/j.bmcl.2008.07.081
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Biochemical and biological properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a mechanism-based inhibitor of fatty acid amide hydrolase.

    Karbarz, Mark J / Luo, Lin / Chang, Leon / Tham, Chui-Se / Palmer, James A / Wilson, Sandy J / Wennerholm, Michelle L / Brown, Sean M / Scott, Brian P / Apodaca, Richard L / Keith, John M / Wu, Jiejun / Breitenbucher, James Guy / Chaplan, Sandra R / Webb, Michael

    Anesthesia and analgesia

    2008  Volume 108, Issue 1, Page(s) 316–329

    Abstract: Fatty acid amide hydrolase (FAAH) is an integral membrane enzyme within the amidase-signature family. It catalyzes the hydrolysis of several endogenous biologically active lipids, including anandamide (arachidonoyl ethanolamide), oleoyl ethanolamide, and ...

    Abstract Fatty acid amide hydrolase (FAAH) is an integral membrane enzyme within the amidase-signature family. It catalyzes the hydrolysis of several endogenous biologically active lipids, including anandamide (arachidonoyl ethanolamide), oleoyl ethanolamide, and palmitoyl ethanolamide. These endogenous FAAH substrates have been shown to be involved in a variety of physiological and pathological processes, including synaptic regulation, regulation of sleep and feeding, locomotor activity, pain and inflammation. Here we describe the biochemical and biological properties of a potent and selective FAAH inhibitor, 4-(3-phenyl-[1,2,4]thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide (JNJ-1661010). The time-dependence of apparent IC(50) values at rat and human recombinant FAAH, dialysis and mass spectrometry data indicate that the acyl piperazinyl fragment of JNJ-1661010 forms a covalent bond with the enzyme. This bond is slowly hydrolyzed, with release of the piperazinyl fragment and recovery of enzyme activity. The lack of inhibition observed in a rat liver esterase assay suggests that JNJ-1661010 is not a general esterase inhibitor. JNJ-1661010 is >100-fold preferentially selective for FAAH-1 when compared to FAAH-2. JNJ-1661010 dose-dependently increases arachidonoyl ethanolamide, oleoyl ethanolamide, and palmitoyl ethanolamide in the rat brain. The compound attenuates tactile allodynia in the rat mild thermal injury model of acute tissue damage and in the rat spinal nerve ligation (Chung) model of neuropathic pain. JNJ-1661010 also diminishes thermal hyperalgesia in the inflammatory rat carrageenan paw model. These data suggest that FAAH inhibitors with modes of action similar to JNJ-1661010 may be useful clinically as broad-spectrum analgesics.
    MeSH term(s) Amides ; Amidohydrolases/antagonists & inhibitors ; Amidohydrolases/genetics ; Amidohydrolases/metabolism ; Analgesics/pharmacology ; Animals ; Arachidonic Acids/metabolism ; Brain/drug effects ; Brain/enzymology ; Carrageenan ; Disease Models, Animal ; Dose-Response Relationship, Drug ; Endocannabinoids ; Enzyme Inhibitors/pharmacology ; Ethanolamines ; Hot Temperature ; Humans ; Hydrolysis ; Isoenzymes ; Kinetics ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Neuralgia/etiology ; Neuralgia/prevention & control ; Oleic Acids/metabolism ; Pain/etiology ; Pain/prevention & control ; Pain Measurement ; Pain Threshold/drug effects ; Palmitic Acids/metabolism ; Piperazines/pharmacology ; Polyunsaturated Alkamides/metabolism ; Rats ; Rats, Sprague-Dawley ; Reaction Time/drug effects ; Recombinant Proteins/antagonists & inhibitors ; Thiadiazoles/pharmacology
    Chemical Substances 4-(3-phenyl-(1,2,4)-thiadiazol-5-yl)piperazine-1-carboxylic acid phenylamide ; Amides ; Analgesics ; Arachidonic Acids ; Endocannabinoids ; Enzyme Inhibitors ; Ethanolamines ; Isoenzymes ; Oleic Acids ; Palmitic Acids ; Piperazines ; Polyunsaturated Alkamides ; Recombinant Proteins ; Thiadiazoles ; oleoylethanolamide (1HI5J9N8E6) ; palmidrol (6R8T1UDM3V) ; Carrageenan (9000-07-1) ; Amidohydrolases (EC 3.5.-) ; FAAH2 protein, human (EC 3.5.-) ; fatty-acid amide hydrolase (EC 3.5.1.-) ; anandamide (UR5G69TJKH)
    Language English
    Publishing date 2008-12-11
    Publishing country United States
    Document type Comparative Study ; Journal Article
    ZDB-ID 80032-6
    ISSN 1526-7598 ; 0003-2999
    ISSN (online) 1526-7598
    ISSN 0003-2999
    DOI 10.1213/ane.0b013e31818c7cbd
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Sphingosine 1-phosphate receptor agonists attenuate relapsing-remitting experimental autoimmune encephalitis in SJL mice.

    Webb, Michael / Tham, Chui-Se / Lin, Fen-Fen / Lariosa-Willingham, Karen / Yu, Naichen / Hale, Jeffrey / Mandala, Suzanne / Chun, Jerold / Rao, Tadimeti S

    Journal of neuroimmunology

    2004  Volume 153, Issue 1-2, Page(s) 108–121

    Abstract: FTY720 is a prodrug for FTY-phosphate, an agonist at four of the five known receptors for sphingosine-1-phosphate (S1P). We show that administration of either FTY720 or FTY-P to SJL mice with established relapsing-remitting experimental autoimmune ... ...

    Abstract FTY720 is a prodrug for FTY-phosphate, an agonist at four of the five known receptors for sphingosine-1-phosphate (S1P). We show that administration of either FTY720 or FTY-P to SJL mice with established relapsing-remitting experimental autoimmune encephalitis (EAE) results in a rapid and sustained improvement in their clinical status, and a reversal of changes in expression of mRNAs encoding some myelin proteins and inflammatory mediators. EAE produced by adoptively transferring lymph node cells from immunized mice to naïve hosts is similarly ameliorated by FTY-P. Treatment with FTY-P is accompanied by a dose-responsive peripheral lymphopoenia.
    MeSH term(s) Animals ; Antineoplastic Agents/therapeutic use ; Disease Models, Animal ; Dose-Response Relationship, Drug ; Drug Interactions ; Encephalomyelitis, Autoimmune, Experimental/blood ; Encephalomyelitis, Autoimmune, Experimental/chemically induced ; Encephalomyelitis, Autoimmune, Experimental/drug therapy ; Encephalomyelitis, Autoimmune, Experimental/metabolism ; Female ; Fingolimod Hydrochloride ; Gene Expression Regulation/immunology ; Granulocyte-Macrophage Colony-Stimulating Factor/genetics ; Granulocyte-Macrophage Colony-Stimulating Factor/metabolism ; Immunosuppressive Agents/pharmacology ; Immunosuppressive Agents/therapeutic use ; Interferon-gamma/genetics ; Interferon-gamma/metabolism ; Lymphocytes/drug effects ; Lymphocytes/physiology ; Lymphopenia/drug therapy ; Lymphopenia/etiology ; Mice ; Mice, Inbred Strains ; Mitoxantrone/therapeutic use ; Molecular Sequence Data ; Myelin Proteins/genetics ; Myelin Proteins/metabolism ; Myelin Proteolipid Protein ; Nitric Oxide Synthase/genetics ; Nitric Oxide Synthase/metabolism ; Nitric Oxide Synthase Type II ; Peptide Fragments ; Propylene Glycols/pharmacology ; Propylene Glycols/therapeutic use ; RNA, Messenger/biosynthesis ; Receptors, G-Protein-Coupled/agonists ; Receptors, Lysophospholipid ; Reverse Transcriptase Polymerase Chain Reaction/methods ; Sphingosine/analogs & derivatives ; Time Factors
    Chemical Substances Antineoplastic Agents ; Immunosuppressive Agents ; Myelin Proteins ; Myelin Proteolipid Protein ; Peptide Fragments ; Propylene Glycols ; RNA, Messenger ; Receptors, G-Protein-Coupled ; Receptors, Lysophospholipid ; myelin proteolipid protein (139-151) ; Interferon-gamma (82115-62-6) ; Granulocyte-Macrophage Colony-Stimulating Factor (83869-56-1) ; Mitoxantrone (BZ114NVM5P) ; Nitric Oxide Synthase (EC 1.14.13.39) ; Nitric Oxide Synthase Type II (EC 1.14.13.39) ; Nos2 protein, mouse (EC 1.14.13.39) ; Fingolimod Hydrochloride (G926EC510T) ; Sphingosine (NGZ37HRE42)
    Language English
    Publishing date 2004-08
    Publishing country Netherlands
    Document type Comparative Study ; Journal Article
    ZDB-ID 8335-5
    ISSN 1872-8421 ; 0165-5728
    ISSN (online) 1872-8421
    ISSN 0165-5728
    DOI 10.1016/j.jneuroim.2004.04.015
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top